Upregulation of Ppp1r1b is associated with gastric, breast, colon, esophageal, lung, and prostate cancers (Avanes et al., 2019), and correlates to worse survival outcomes in pancreatic cancer (Tiwari et al., 2020). The gene discussed is PPP1R1B; the disease is prostate carcinoma.